Integrichain Blog

Blog

Net Revenue Pharma
Access Transformation Jen Sharpe Walt Worsham
June 3, 2025

Optimizing Net Revenue Modeling Under New Market Dynamics

4 Minute Read

This year's Asembia conference was highly impactful, offering deep insights into pharmaceutical manufacturers' top challenges and future commercial data needs, particularly highlighting the growing demand for real-time, integrated data...

Data Centric

Access Transformation Lauren Labik
June 3, 2025

Bringing Clarity to Complexity: Thoughts from Asembia 2025

3 Minute Read

This year's Asembia conference was highly impactful, offering deep insights into pharmaceutical manufacturers' top challenges and future commercial data needs, particularly highlighting the growing demand for real-time, integrated data...

How Direct-to-Patient Pharma Policies Are Changing

Market Access Rick Moore Joseph Ventre
May 21, 2025

What MFN Pricing Initiatives Mean for Manufacturers: Key Insights from the...

3 Minute Read

May 20, 2025, the U.S. Department of Health and Human Services (HHS) issued a significant update on the Executive Order “Delivering Most Favored Nation Prescription Drug Pricing to...

Navigating specialty pharmacy distribution model changes

Market Access Reena Patel
April 24, 2025

Navigating Pharma Distribution Models: Insights from Industry Leaders Part 2

5 Minute Read

Part 2 of our blog examines how new distribution models and market access trends will impact future pharmaceutical strategy.

How Direct-to-Patient Pharma Policies Are Changing

Market Access Blogs Jordan Boruff Ankith Pokkuluri Rick Dutt
March 26, 2025

Direct-to-Patient & Fair Drug Pricing: Reshaping the Pharmacy Landscape

6 Minute Read

This month, we offer commentary on two topics around Direct-to-Patient and the Impact of Maximum Fair Prices on the First 10 Medicare-Negotiated Drugs.

branded prescription drug fee

Contracts & Pricing Nick Lynch
March 13, 2025

2025 Branded Prescription Drug Fees Considerations

3 Minute Read

Keep up-to-date on Branded Prescription Drug Fees with this summary of critical insights from Nick Lynch, Partner at IntegriChain, covering key deadlines and factors.

The impact of policy changes on pharma market access

Market Access Reena Patel
March 11, 2025

Navigating the Impact of Policy Changes on Pharma Market Access: Insights...

4 Minute Read

The pharmaceutical industry is facing unprecedented challenges as market access dynamics continue to evolve. To navigate these complexities, companies must rethink channel, pricing, contracting, and patient access strategies.

Navigating Fair Market Value Pharma Strategies

Contracts & Pricing Nick Lynch
March 4, 2025

Pharma Fair Market Value Strategies & Bona Fide Service Fees: 2024/2025...

4 Minute Read

In this blog, we recap the key insights shared by Nick Lynch, Partner at IntegriChain, and Suriya Janarthanan, Associate Director at Novartis, on how manufacturers can navigate FMV and...

pharma data strategy with AI/ML

Contracts & Pricing Jeff Uccello
February 28, 2025

Build a Next-Generation Commercial Data Strategy with AI & ML

2 Minute Read

In today’s rapidly evolving pharmaceutical landscape, creating an effective commercial data strategy is critical for achieving success.

new pharmaceutical government pricing tools

Government Pricing Carina Wang Jonathan Brier
January 24, 2025

Emerging Tools & Challenges in Pharmaceutical Government Pricing

2 Minute Read

The pharmaceutical industry faces increasing difficulty accurately calculating and reporting government prices due to stringent regulations and recent complex changes.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article